Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Apeptide is a Shanghai-based peptide synthesis and biochemical products company serving research and drug discovery customers. The company markets custom peptide synthesis, modified peptides, amino acids, fluorescent dyes, protein expression, ELISA kits, peptide libraries, purification and sequencing services, and small-molecule custom synthesis. Its catalog and service offering appears focused on research-use products rather than development of a proprietary therapeutic pipeline. Apeptide positions itself as a high-purity peptide manufacturer and supplier for laboratories, biotech companies, and pharmaceutical research groups. The business is best characterized as a commercial life sciences tools and contract synthesis company rather than a clinical-stage therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Apeptide.